BBK Worldwide Launches Expanded Suite Of Retention Products To Support Clinical Trial Study Sites - Applied Clinical Trials

ADVERTISEMENT

See our 2012 Buyers Guide Digital Edition.
Find Pharma Search Engine
BBK Worldwide Launches Expanded Suite Of Retention Products To Support Clinical Trial Study Sites

Source: Company News Release

BBK Worldwide, the global leader in patient recruitment and retention for clinical research, announced today an expanded suite of products that streamlines retention efforts at the site level. Among these products are the Ready. Set. Go.SM Card (RSGSM Card), Ready. Set. Go.SM Ride (RSGSM Ride), and Ready. Set. Go.SM Minder (RSGSM Minder). These products are customized for today’s clinical research coordinator who is tasked with multiple responsibilities and demands. Through the efficiencies these products create, the clinical research coordinator is allowed to focus his or her efforts on other study-related priorities.

Only BBK Worldwide’s system is designed to minimize the need for acquiring personal and identifying patient information, a requirement of competitor programs directly resulting in sub-optimal ethics committee and patient support for these necessary retention and compliance services.

Each individual product addresses a specific retention function. The RSG Card is a global reimbursement solution for clinical study participants. “With the RSG Card, we are transforming the way the industry reimburses study participants – making it easier and more efficient for both patients and study staff,” comments Mike Johnson, Product Development, BBK Worldwide. “Management of the card is streamlined at the site level through TrialCentralNetSM, the leading online patient recruitment management system,” continues Johnson.

RSG Ride offers a convenient way to schedule and manage patient transportation. BBK specialists coordinate travel to and from approved study visits, fostering study compliance and minimizing the need for site staff to reschedule missed appointments. “RSG Ride provides an alternative choice in transportation for study participants who may have difficulty finding transportation to and from study appointments,” comments Jennifer Dinkel, Strategic Consultant, BBK Worldwide.

RSG Minder is a customized mobile platform that supports study participants and assists them in managing their study obligations. “Study participants have access to functionality that allows them to track upcoming study visits and schedule convenient reminders. In addition, content functionality allows BBK to send notifications to opted-in patients about upcoming visit reminders, post-visit follow-up, and general study information and updates,” comments Johnson.

To learn more about these and other BBK products, visit shop.BBKWorldwide.com. Clinical research professionals can find discounts on site support services within BBK’s portfolio of recruitment and retention tools as part of February’s online event.

Related Links:

Lost to Follow-Up Survey Results

Patient Recruitment and Retention in CNS Trials

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma
Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
94%
Borrow lightly from EMA's pathway program?
0%
Create entirely its own pathway program?
6%
View Results
Untitled Document
Source: Company News Release,
Click here